Forte Biosciences, Inc. (FBRX)
76.99
0.00 (0.00%)
USD |
NASDAQ |
Oct 02, 16:00
Forte Biosciences 1 Year Total Returns (Daily) : 472.8% for Oct. 2, 2026
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| October 02, 2026 | 472.8% |
| October 01, 2026 | 430.2% |
| September 30, 2026 | 413.3% |
| September 29, 2026 | 431.7% |
| September 28, 2026 | 456.3% |
| September 25, 2026 | 440.3% |
| September 24, 2026 | 413.3% |
| September 23, 2026 | 385.4% |
| September 22, 2026 | 420.7% |
| September 21, 2026 | 469.9% |
| September 18, 2026 | 482.8% |
| September 17, 2026 | 543.7% |
| September 16, 2026 | 524.4% |
| September 15, 2026 | 570.6% |
| September 14, 2026 | 629.1% |
| September 11, 2026 | 636.0% |
| September 10, 2026 | 607.0% |
| September 09, 2026 | 596.1% |
| September 08, 2026 | 591.7% |
| September 04, 2026 | 602.5% |
| September 03, 2026 | 595.5% |
| September 02, 2026 | 596.7% |
| September 01, 2026 | 599.9% |
| August 31, 2026 | 599.9% |
| August 28, 2026 | 585.6% |
| Date | Value |
|---|---|
| August 27, 2026 | 589.9% |
| August 26, 2026 | 583.7% |
| August 25, 2026 | 580.2% |
| August 24, 2026 | 573.2% |
| August 21, 2026 | 592.3% |
| August 20, 2026 | 553.8% |
| August 19, 2026 | 554.5% |
| August 18, 2026 | 545.5% |
| August 17, 2026 | 564.6% |
| August 14, 2026 | 610.1% |
| August 13, 2026 | 627.2% |
| August 12, 2026 | 613.6% |
| August 11, 2026 | 631.4% |
| August 10, 2026 | 655.0% |
| August 07, 2026 | 645.5% |
| August 06, 2026 | 626.2% |
| August 05, 2026 | 689.8% |
| August 04, 2026 | 682.0% |
| August 03, 2026 | 697.2% |
| July 31, 2026 | 667.5% |
| July 30, 2026 | 655.8% |
| July 29, 2026 | 617.9% |
| July 28, 2026 | 559.1% |
| July 27, 2026 | 559.5% |
| July 24, 2026 | 409.6% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| argenx SE | 16.12% |
| ACADIA Pharmaceuticals, Inc. | -6.69% |
| Alnylam Pharmaceuticals, Inc. | -52.34% |
| Savara, Inc. | 37.82% |
| Vericel Corp. | 27.38% |